Skip to main navigation Skip to search Skip to main content

Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease

  • Daniela Calandrella
  • , Luigi Michele Antonio Romito
  • , Antonio Emanuele Elia
  • , Francesca Del Sorbo
  • , Caterina Bagella
  • , Massimo Falsitta
  • , Alberto Albanese
  • IRCCS Fondazione Istituto Neurologico Carlo Besta - Milano
  • IRCCS Istituto nazionale tumori Fondazione Giovanni Pascale - Napoli

Research output: Contribution to journalArticlepeer-review

Abstract

We performed a real-life observation of patients with Parkinson disease (PD) who received duodenal levodopa infusion (DLI) to determine which adverse events caused treatment discontinuation and when such events occurred.
Original languageEnglish
Pages (from-to)1669-1672
Number of pages4
JournalNeurology
Volume84
DOIs
Publication statusPublished - 2015

Keywords

  • Parkinson disease

Fingerprint

Dive into the research topics of 'Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease'. Together they form a unique fingerprint.

Cite this